Literature DB >> 32360815

The relationship between cingulum bundle integrity and different aspects of executive functions in chronic schizophrenia.

Ernest Tyburski1, Monika Mak2, Agnieszka Samochowiec3, Piotr Plichta2, Maksymilian Bielecki2, Katarzyna Rek-Owodziń2, Piotr Podwalski4, Krzysztof Rudkowski4, Katarzyna Waszczuk4, Justyna Pełka-Wysiecka4, Jolanta Kucharska-Mazur4, Wojciech Andrusewicz5, Błażej Misiak6, Magdalena Kerestey3, Anna Michalczyk4, Shane T Mueller7, Leszek Sagan5, Jerzy Samochowiec8.   

Abstract

BACKGROUND: Evidence suggests that disruption in the cingulum bundle (CB) may influence executive dysfunctions in schizophrenia, but findings are still inconsistent. Using diffusion tensor imaging tractography, we investigated the differences in fiber integrity between schizophrenia patients and healthy controls together with the association between fiber integrity and executive functions.
METHODS: Thirty-two patients with chronic schizophrenia and 24 healthy controls took part in the study. Both groups were matched for age, sex, and years of education. Assessment of cognitive functions was performed using the Berg Card Sorting Test (BCST), the Color Trail Test (CTT), and the Stroop Color-Word Test (SCWT).
RESULTS: Results showed group differences, bilaterally (left and right) in fractional anisotropy (FA) of the CB, where patients showed less anisotropy than controls. Moreover, normal asymmetry (left FA > right FA) in the CB in schizophrenia was found. There were no group differences in mean diffusivity (MD). Patients had a similar but reduced profile of executive functions compared to healthy controls. However, when premorbid IQ was controlled for, the differences were no longer statistically significant. In schizophrenia patients, a negative correlation was found between FA of the left CB and perseverative errors in the BCST.
CONCLUSIONS: These findings provide evidence that CB disruption appears in schizophrenia patients and might account for impairments of executive processes, including concept formation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cingulum bundle; Diffusion tensor imaging; Executive functions; Fractional anisotropy; Schizophrenia; White matter integrity

Mesh:

Year:  2020        PMID: 32360815     DOI: 10.1016/j.pnpbp.2020.109955

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  4 in total

1.  The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.

Authors:  Katarzyna Rek-Owodziń; Ernest Tyburski; Piotr Plichta; Katarzyna Waszczuk; Maksymilian Bielecki; Krzysztof Wietrzyński; Piotr Podwalski; Krzysztof Rudkowski; Anna Michalczyk; Tomasz Grąźlewski; Leszek Sagan; Jolanta Kucharska-Mazur; Jerzy Samochowiec; Monika Mak
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

2.  DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia.

Authors:  Xiaofen Zong; Qinran Zhang; Changchun He; Xinyue Huang; Jiangbo Zhang; Gaohua Wang; Luxian Lv; Deen Sang; Xiufen Zou; Huafu Chen; Junjie Zheng; Maolin Hu
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

3.  Gut Microbiome Composition Linked to Inflammatory Factors and Cognitive Functions in First-Episode, Drug-Naive Major Depressive Disorder Patients.

Authors:  Penghong Liu; Mingxue Gao; Zhifen Liu; Yanyan Zhang; Hongwei Tu; Lei Lei; Peiyi Wu; Aixia Zhang; Chunxia Yang; Gaizhi Li; Ning Sun; Kerang Zhang
Journal:  Front Neurosci       Date:  2022-01-28       Impact factor: 4.677

4.  Acute conceptual disorganization in untreated first-episode psychosis: a combined magnetic resonance spectroscopy and diffusion imaging study of the cingulum.

Authors:  Yunzhi Pan; Kara Dempster; Peter Jeon; Jean Théberge; Ali R Khan; Lena Palaniyappan
Journal:  J Psychiatry Neurosci       Date:  2021-04-27       Impact factor: 6.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.